Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications
NCT ID: NCT01876836
Last Updated: 2013-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
120 participants
INTERVENTIONAL
2013-07-31
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. C-LMA
Compare the effect on gastroeosephageal reflux Postoperative complicatios.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Gastric Volume in I-gel and ProSeal Laryngeal Mask Airways
NCT07138092
Comparison of I-gel LMA, Classical LMA With a New Supraglottic Airway the Baska Mask® in Urological Surgery
NCT03002857
I-gel vs LMA Supreme in Laparoscopic Gynecological Surgery
NCT02923427
Laryngeal Mask Supreme and I-Gel in Edentulate Geriatric Patients
NCT03760679
Comparison of Clinical Performance of Supraglottic Airway Devices
NCT06850675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. i-gel
2. C-LMA Volume controlled ventilation, general anesthesia Asses Gastroeosephageal reflux, sore throat, coughing, dysphagia,dysphonia recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
i-gel
i-gel placed after induction
i-gel
i-gel placed after induction
C-LMA
C-LMA placed after induction
C-LMA
placed after induction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
i-gel
i-gel placed after induction
C-LMA
placed after induction
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult
* Elective surgery
* Bladder tumour
* Prostat hyperplasi
Exclusion Criteria
* Hiatal hernia
* Gastroeosephageal reflux disease
19 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diskapi Yildirim Beyazit Education and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reyhan Polat
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reyhan Polat, MD
Role: PRINCIPAL_INVESTIGATOR
Diskapi Yildirim Beyazit Education and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
DiskapiYBERH
Ankara, Altındağ, Turkey (Türkiye)
DiskapiYBERH
Ankara, Altındağ, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.